Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
Sep 8, 2026, 2:23 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $14.34 million as of September 8, 2026. Its market cap has decreased by -37.61% in one year.
Market Cap
14.34M
Enterprise Value
26.93M
Revenue
250.00K
Ranking
n/a
PE Ratio
0.06
Stock Price
$0.03
ChartMarket Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 14.34M, an increase of 56.82%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 14.34M | -61.38% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 19.42M |
| EOM Pharmaceuticals Holdings | 19.11M |
| Finch Therapeutics Group | 16.62M |
| ZIVO Bioscience | 14.95M |
| Anebulo Pharmaceuticals | 14.63M |
| Synlogic | 13.69M |
| Inhibitor Therapeutics | 12.87M |
| Brainstorm Cell Therapeutics | 11.59M |